Clinical Trial Update: How Desloratadine (Clarinex, Aerius) Affects Quality of Life in Patients With Chronic Idiopathic Urticaria (Have Had Hives for 6 Weeks or Longer)(Study P02988) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating desloratadine (Clarinex, Aerius) and its impact on quality of life in chronic idiopathic urticaria patients with hives for 6 weeks or l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Urticaria

Drugs mentioned

• Desloratadine (desloratadine)

Snippet

Sponsor: Organon and Co | Conditions: Urticaria | Phase 3 | Status: COMPLETED